{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"15.94","spread":"15.94","value":"-28.1"},{"groupId":"OG001","lowerLimit":"23.96","spread":"23.96","value":"8.9"}]}],"title":"ANG 2: Cycle 1 Day 15"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.53","spread":"16.53","value":"-28.8"},{"groupId":"OG001","lowerLimit":"24.06","spread":"24.06","value":"-0.9"}]}],"title":"ANG 2: Cycle 2 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"23.23","spread":"23.23","value":"-32.2"},{"groupId":"OG001","lowerLimit":"26.62","spread":"26.62","value":"0.5"}]}],"title":"ANG 2: Cycle 3 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"22.91","spread":"22.91","value":"-35.6"},{"groupId":"OG001","lowerLimit":"20.05","spread":"20.05","value":"-4.5"}]}],"title":"ANG 2: Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"19.83","spread":"19.83","value":"-38.9"},{"groupId":"OG001","lowerLimit":"23.25","spread":"23.25","value":"7.0"}]}],"title":"ANG 2: Cycle 5 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"23.59","spread":"23.59","value":"-36.7"},{"groupId":"OG001","lowerLimit":"24.82","spread":"24.82","value":"-3.6"}]}],"title":"ANG 2: Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"21.20","spread":"21.20","value":"-41.4"},{"groupId":"OG001","lowerLimit":"32.83","spread":"32.83","value":"1.0"}]}],"title":"ANG 2: Cycle 7 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"25.33","spread":"25.33","value":"-40.2"},{"groupId":"OG001","lowerLimit":"31.26","spread":"31.26","value":"-6.7"}]}],"title":"ANG 2: Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"14.04","spread":"14.04","value":"-39.6"},{"groupId":"OG001","lowerLimit":"29.68","spread":"29.68","value":"-1.1"}]}],"title":"ANG 2: Cycle 9 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"99.13","spread":"99.13","value":"11.7"},{"groupId":"OG001","lowerLimit":"27.88","spread":"27.88","value":"16.8"}]}],"title":"ANG 2: Off-Treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"155.01","spread":"155.01","value":"75.0"},{"groupId":"OG001","lowerLimit":"83.65","spread":"83.65","value":"1.3"}]}],"title":"FGF19: Cycle 1 Day 15"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"134.26","spread":"134.26","value":"66.5"},{"groupId":"OG001","lowerLimit":"119.65","spread":"119.65","value":"36.6"}]}],"title":"FGF19: Cycle 2 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"123.85","spread":"123.85","value":"86.9"},{"groupId":"OG001","lowerLimit":"70.58","spread":"70.58","value":"22.8"}]}],"title":"FGF19: Cycle 3 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"602.11","spread":"602.11","value":"208.1"},{"groupId":"OG001","lowerLimit":"214.14","spread":"214.14","value":"46.8"}]}],"title":"FGF19: Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"228.37","spread":"228.37","value":"152.8"},{"groupId":"OG001","lowerLimit":"40.36","spread":"40.36","value":"-1.0"}]}],"title":"FGF19: Cycle 5 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"203.81","spread":"203.81","value":"119.8"},{"groupId":"OG001","lowerLimit":"67.13","spread":"67.13","value":"26.9"}]}],"title":"FGF19: Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"101.97","spread":"101.97","value":"64.4"},{"groupId":"OG001","lowerLimit":"57.39","spread":"57.39","value":"-5.9"}]}],"title":"FGF19: Cycle 7 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"135.31","spread":"135.31","value":"95.8"},{"groupId":"OG001","lowerLimit":"113.79","spread":"113.79","value":"53.9"}]}],"title":"FGF19: Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"202.00","spread":"202.00","value":"159.3"},{"groupId":"OG001","lowerLimit":"109.46","spread":"109.46","value":"56.6"}]}],"title":"FGF19: Cycle 9 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"270.73","spread":"270.73","value":"140.1"},{"groupId":"OG001","lowerLimit":"64.17","spread":"64.17","value":"9.0"}]}],"title":"FGF19: Off-Treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"75.22","spread":"75.22","value":"22.0"},{"groupId":"OG001","lowerLimit":"43.14","spread":"43.14","value":"4.0"}]}],"title":"FGF 21: Cycle 1 Day 15"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"77.44","spread":"77.44","value":"15.7"},{"groupId":"OG001","lowerLimit":"57.18","spread":"57.18","value":"18.6"}]}],"title":"FGF 21: Cycle 2 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"38.3","spread":"38.3","value":"38.3"},{"groupId":"OG001","lowerLimit":"76.43","spread":"76.43","value":"49.4"}]}],"title":"FGF 21: Cycle 3 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"145.43","spread":"145.43","value":"42.9"},{"groupId":"OG001","lowerLimit":"70.63","spread":"70.63","value":"32.8"}]}],"title":"FGF 21: Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"95.97","spread":"95.97","value":"41.0"},{"groupId":"OG001","lowerLimit":"43.15","spread":"43.15","value":"31.1"}]}],"title":"FGF 21: Cycle 5 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"168.22","spread":"168.22","value":"52.6"},{"groupId":"OG001","lowerLimit":"40.90","spread":"40.90","value":"23.2"}]}],"title":"FGF 21: Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"128.34","spread":"128.34","value":"63.4"},{"groupId":"OG001","lowerLimit":"53.84","spread":"53.84","value":"23.7"}]}],"title":"FGF 21: Cycle 7 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"115.53","spread":"115.53","value":"38.3"},{"groupId":"OG001","lowerLimit":"68.51","spread":"68.51","value":"17.0"}]}],"title":"FGF 21 : Cycle 8 Day1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"108.39","spread":"108.39","value":"59.1"},{"groupId":"OG001","lowerLimit":"103.55","spread":"103.55","value":"68.9"}]}],"title":"FGF 21: Cycle 9 Day1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"340.51","spread":"340.51","value":"141.4"},{"groupId":"OG001","lowerLimit":"183.28","spread":"183.28","value":"104.9"}]}],"title":"FGF 21: Off-Treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"49.01","spread":"49.01","value":"23.9"},{"groupId":"OG001","lowerLimit":"36.14","spread":"36.14","value":"-16.3"}]}],"title":"FGF 23: Cycle 1 Day15"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"56.91","spread":"56.91","value":"20.9"},{"groupId":"OG001","lowerLimit":"48.18","spread":"48.18","value":"-6.2"}]}],"title":"FGF 23: Cycle 2 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"45.27","spread":"45.27","value":"25.5"},{"groupId":"OG001","lowerLimit":"75.25","spread":"75.25","value":"17.3"}]}],"title":"FGF 23: Cycle 3 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"48.38","spread":"48.38","value":"29.5"},{"groupId":"OG001","lowerLimit":"49.29","spread":"49.29","value":"14.2"}]}],"title":"FGF 23: Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"63.69","spread":"63.69","value":"29.6"},{"groupId":"OG001","lowerLimit":"47.28","spread":"47.28","value":"1.0"}]}],"title":"FGF 23: Cycle 5 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"54.57","spread":"54.57","value":"26.3"},{"groupId":"OG001","lowerLimit":"46.15","spread":"46.15","value":"-10.6"}]}],"title":"FGF 23: Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"57.44","spread":"57.44","value":"31.5"},{"groupId":"OG001","lowerLimit":"46.95","spread":"46.95","value":"0.7"}]}],"title":"FGF 23: Cycle 7 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"67.35","spread":"67.35","value":"38.1"},{"groupId":"OG001","lowerLimit":"43.84","spread":"43.84","value":"2.8"}]}],"title":"FGF 23: Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"62.58","spread":"62.58","value":"23.2"},{"groupId":"OG001","lowerLimit":"38.74","spread":"38.74","value":"0.5"}]}],"title":"FGF 23: Cycle 9 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"73.59","spread":"73.59","value":"17.8"},{"groupId":"OG001","lowerLimit":"47.11","spread":"47.11","value":"14.2"}]}],"title":"FGF 23: Off-Treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"171.41","spread":"171.41","value":"80.0"},{"groupId":"OG001","lowerLimit":"256.04","spread":"256.04","value":"166.9"}]}],"title":"PIVKA-II: Cycle 1 Day 15"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"329.33","spread":"329.33","value":"169.7"},{"groupId":"OG001","lowerLimit":"416.82","spread":"416.82","value":"243.8"}]}],"title":"PIVKA-II: Cycle 2 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"611.40","spread":"611.40","value":"252.4"},{"groupId":"OG001","lowerLimit":"281.45","spread":"281.45","value":"218.7"}]}],"title":"PIVKA-II: Cycle 3 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"812.45","spread":"812.45","value":"371.7"},{"groupId":"OG001","lowerLimit":"348.80","spread":"348.80","value":"196.2"}]}],"title":"PIVKA-II: Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1752.64","spread":"1752.64","value":"628.2"},{"groupId":"OG001","lowerLimit":"766.59","spread":"766.59","value":"369.5"}]}],"title":"PIVKA-II: Cycle 5 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2746.41","spread":"2746.41","value":"648.7"},{"groupId":"OG001","lowerLimit":"554.27","spread":"554.27","value":"415.7"}]}],"title":"PIVKA-II: Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"352.75","spread":"352.75","value":"184.8"},{"groupId":"OG001","lowerLimit":"1226.58","spread":"1226.58","value":"703.6"}]}],"title":"PIVKA-II: Cycle 7 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"481.53","spread":"481.53","value":"277.8"},{"groupId":"OG001","lowerLimit":"1257.87","spread":"1257.87","value":"724.0"}]}],"title":"PIVKA-II: Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"577.21","spread":"577.21","value":"318.8"},{"groupId":"OG001","lowerLimit":"1492.93","spread":"1492.93","value":"859.1"}]}],"title":"PIVKA-II: Cycle 9 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1827.42","spread":"1827.42","value":"809.3"},{"groupId":"OG001","lowerLimit":"489.60","spread":"489.60","value":"272.5"}]}],"title":"PIVKA-II: Off-Treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"300.21","spread":"300.21","value":"157.5"},{"groupId":"OG001","lowerLimit":"118.43","spread":"118.43","value":"97.4"}]}],"title":"VEGF: Cycle 1 Day 15"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"333.85","spread":"333.85","value":"128.9"},{"groupId":"OG001","lowerLimit":"180.80","spread":"180.80","value":"94.0"}]}],"title":"VEGF: Cycle 2 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"162.39","spread":"162.39","value":"97.7"},{"groupId":"OG001","lowerLimit":"124.58","spread":"124.58","value":"66.0"}]}],"title":"VEGF: Cycle 3 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"231.19","spread":"231.19","value":"113.4"},{"groupId":"OG001","lowerLimit":"111.20","spread":"111.20","value":"76.1"}]}],"title":"VEGF: Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"249.59","spread":"249.59","value":"132.4"},{"groupId":"OG001","lowerLimit":"215.57","spread":"215.57","value":"116.2"}]}],"title":"VEGF: Cycle 5 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"219.36","spread":"219.36","value":"113.1"},{"groupId":"OG001","lowerLimit":"341.12","spread":"341.12","value":"130.9"}]}],"title":"VEGF: Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"383.43","spread":"383.43","value":"133.1"},{"groupId":"OG001","lowerLimit":"173.77","spread":"173.77","value":"96.9"}]}],"title":"VEGF: Cycle 7 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"349.58","spread":"349.58","value":"148.7"},{"groupId":"OG001","lowerLimit":"399.67","spread":"399.67","value":"181.1"}]}],"title":"VEGF: Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"215.05","spread":"215.05","value":"129.6"},{"groupId":"OG001","lowerLimit":"267.61","spread":"267.61","value":"135.6"}]}],"title":"VEGF: Cycle 9 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"266.64","spread":"266.64","value":"127.1"},{"groupId":"OG001","lowerLimit":"304.31","spread":"304.31","value":"147.8"}]}],"title":"VEGF: Off-Treatment"}],"denoms":[{"counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"48"}],"units":"Participants"}],"description":"The serum biomarkers analysed were angiopoietin-2 (ANG2), fibroblast growth factor 19 (FGF19), fibroblast growth factor 21 (FGF21), fibroblast growth factor 23 (FGF23) and vascular endothelial growth factor (VEGF) as blood serum biomarkers, and protein induced by vitamin K absence or antagonist-II (PIVKA-II) as a blood tumor marker in serum. As planned, data for this pre-specified endpoint was collected and analyzed up to the primary completion date.","dispersionType":"Standard Deviation","groups":[{"description":"Subjects received lenvatinib capsules 12 milligram (mg) based on the participant's body weight greater than or equal to (\\>=) 60 kilogram (kg) or 8 mg based on the subject's body weight less than (\\<) 60 kg at baseline, orally, once daily (QD) in continuous 28-day treatment cycles up to documented disease progression, development of unacceptable toxicity, participant request, or withdrawal of consent.","id":"OG000","title":"Lenvatinib"},{"description":"Participants received sorafenib 400 mg tablets, orally, twice daily (BID) in continuous 28-day treatment cycles up to documented disease progression, development of unacceptable toxicity, participant request, or withdrawal of consent.","id":"OG001","title":"Sorafenib"}],"paramType":"MEDIAN","populationDescription":"The pharmacodynamics (PD) analysis set included all participants who received at least 1 dose of study drug and had evaluable PD data. Here \"n\" was participants who were evaluable for the outcome measure at given time points.","reportingStatus":"POSTED","timeFrame":"Cycle 1 Day 15, Cycle 2 Day 1, Cycle 3 Day 1, Cycle 4 Day 1, Cycle 5 Day 1, Cycle 6 Day 1, Cycle 7 Day 1, Cycle 8 Day 1, Cycle 9 Day 1 and at the Off-Treatment Visit (approximately up to 3.8 years)","title":"Percent Change From Baseline in Serum Biomarker","type":"OTHER_PRE_SPECIFIED","unitOfMeasure":"percent change"}